154 related articles for article (PubMed ID: 11092010)
1. [Establishing a cytogenetic and morphological progression models of invasive breast cancer. Comparative genomic hybridization (CGH) in malignant and premalignant tumors of the female breast].
Bürger H; Poremba C; Diallo R; Dockhorn-Dworniczak B; Böcker W
Pathologe; 2000 Sep; 21(5):375-82. PubMed ID: 11092010
[TBL] [Abstract][Full Text] [Related]
2. Clonal relationship between closely approximated low-grade ductal and lobular lesions in the breast: a molecular study of 10 cases.
Wagner PL; Kitabayashi N; Chen YT; Shin SJ
Am J Clin Pathol; 2009 Dec; 132(6):871-6. PubMed ID: 19926578
[TBL] [Abstract][Full Text] [Related]
3. Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast.
Buerger H; Simon R; Schäfer KL; Diallo R; Littmann R; Poremba C; van Diest PJ; Dockhorn-Dworniczak B; Böcker W
Mol Pathol; 2000 Jun; 53(3):118-21. PubMed ID: 10897329
[TBL] [Abstract][Full Text] [Related]
4. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
Shin SJ; Simpson PT; Da Silva L; Jayanthan J; Reid L; Lakhani SR; Rosen PP
Am J Surg Pathol; 2009 Apr; 33(4):496-504. PubMed ID: 19047897
[TBL] [Abstract][Full Text] [Related]
5. Genetic changes in intraductal breast cancer detected by comparative genomic hybridization.
Kuukasjärvi T; Tanner M; Pennanen S; Karhu R; Kallioniemi OP; Isola J
Am J Pathol; 1997 Apr; 150(4):1465-71. PubMed ID: 9095001
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of premalignant lesions in prophylactically removed breasts from women at hereditary risk for breast cancer.
Hoogerbrugge N; Bult P; de Widt-Levert LM; Beex LV; Kiemeney LA; Ligtenberg MJ; Massuger LF; Boetes C; Manders P; Brunner HG
J Clin Oncol; 2003 Jan; 21(1):41-5. PubMed ID: 12506168
[TBL] [Abstract][Full Text] [Related]
7. Premalignant and in situ breast disease: biology and clinical implications.
Arpino G; Laucirica R; Elledge RM
Ann Intern Med; 2005 Sep; 143(6):446-57. PubMed ID: 16172443
[TBL] [Abstract][Full Text] [Related]
8. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric DNA analysis of breast cancers with predominance of carcinoma in situ: a comparison of the premalignant and malignant components.
Ottesen GL; Christensen IJ; Larsen JK; Hansen B; Andersen AJ
Clin Cancer Res; 1995 Aug; 1(8):881-8. PubMed ID: 9816058
[TBL] [Abstract][Full Text] [Related]
10. Definition of precancerous and high-risk mammary lesions.
Bégin LR
Can J Surg; 1985 May; 28(3):248-51. PubMed ID: 2986807
[TBL] [Abstract][Full Text] [Related]
11. Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns.
Boecker W; Buerger H; Schmitz K; Ellis IA; van Diest PJ; Sinn HP; Geradts J; Diallo R; Poremba C; Herbst H
J Pathol; 2001 Nov; 195(4):415-21. PubMed ID: 11745672
[TBL] [Abstract][Full Text] [Related]
12. The molecular genetics of breast cancer: the contribution of comparative genomic hybridization.
Reis-Filho JS; Simpson PT; Gale T; Lakhani SR
Pathol Res Pract; 2005; 201(11):713-25. PubMed ID: 16325514
[TBL] [Abstract][Full Text] [Related]
13. Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomas.
Robanus-Maandag EC; Bosch CA; Kristel PM; Hart AA; Faneyte IF; Nederlof PM; Peterse JL; van de Vijver MJ
J Pathol; 2003 Sep; 201(1):75-82. PubMed ID: 12950019
[TBL] [Abstract][Full Text] [Related]
14. Increasing chromosome 1 copy number parallels histological progression in breast carcinogenesis.
Cummings MC; Aubele M; Mattis A; Purdie D; Hutzler P; Höfler H; Werner M
Br J Cancer; 2000 Mar; 82(6):1204-10. PubMed ID: 10735507
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneous chromosomal aberrations in intraductal breast lesions adjacent to invasive carcinoma.
Aubele M; Cummings M; Walsch A; Zitzelsberger H; Nährig J; Höfler H; Werner M
Anal Cell Pathol; 2000; 20(1):17-24. PubMed ID: 11007434
[TBL] [Abstract][Full Text] [Related]
16. Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor.
Xu S; Wei B; Zhang H; Qing M; Bu H
Oncol Rep; 2008 Jun; 19(6):1469-75. PubMed ID: 18497952
[TBL] [Abstract][Full Text] [Related]
17. [Pathology of premalignant and malignant diseases of the female breast].
Prechtel K
Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1989; ():897-900. PubMed ID: 2577661
[TBL] [Abstract][Full Text] [Related]
18. Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways.
Buerger H; Otterbach F; Simon R; Poremba C; Diallo R; Decker T; Riethdorf L; Brinkschmidt C; Dockhorn-Dworniczak B; Boecker W
J Pathol; 1999 Mar; 187(4):396-402. PubMed ID: 10398097
[TBL] [Abstract][Full Text] [Related]
19. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H
Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
[TBL] [Abstract][Full Text] [Related]
20. Expression of c-erbB-2 in in situ and in adjacent invasive ductal adenocarcinomas of the female breast.
Maguire HC; Hellman ME; Greene MI; Yeh I
Pathobiology; 1992; 60(3):117-21. PubMed ID: 1352687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
